PB 95 of 2014
National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 11)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 25 November 2014
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 11).
(2) This Determination may also be cited as PB 95 of 2014.
2 Commencement
This Determination commences on 1 December 2014.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Adapalene with benzoyl peroxide
Omit
Adefovir
[2] Schedule 1, after item dealing with Botulinum toxin type A purified neurotoxin complex
Insert
Brentuximab vedotin
[3] Schedule 1, after item dealing with Cefuroxime
Omit
Celecoxib
[4] Schedule 1, after item dealing with Dutasteride
Insert
Eculizumab
[5] Schedule 1, after item dealing with Entecavir
Insert
Enzalutamide
[6] Schedule 1, after item dealing with Glycerol
Insert
Glycine with carbohydrate
[7] Schedule 1, after item dealing with Ivabradine
Insert
Ivacaftor
[8] Schedule 1, after item dealing with Miconazole
Insert
Midazolam
[9] Schedule 1, after item dealing with Oxprenolol
Omit
Oxycodone
[10] Schedule 1, after item dealing with Quinagolide
Omit
Raloxifene
[11] Schedule 1, after item dealing with Silver Sulfadiazine
Insert
Simeprevir
[12] Schedule 1, after item dealing with Tyrosine with carbohydrate
Insert
Umeclidinium
[13] Schedule 2, after item dealing with Acitretin
Insert
Adefovir
[14] Schedule 2, after item dealing with Ceftriaxone
Insert
Celecoxib
[15] Schedule 2, after item dealing with Diphenoxylate with atropine
Insert
Dipyridamole with Aspirin
[16] Schedule 2, after item dealing with Donepezil
Insert
Dorzolamide with timolol
[17] Schedule 2, after item dealing with Oxybutynin
Insert
Oxycodone
[18] Schedule 2, after item dealing with Rabeprazole
Insert
Raloxifene
[18] Schedule 2, after item dealing with Valsartan
Insert
Valsartan with hydrochlorothiazide